NCT05704413 Digestive Biobank for Exploring Microbiota-host Interactions
| NCT ID | NCT05704413 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Inflammatory Bowel Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-06-17 |
| Primary Completion | 2026-09-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-06-17 with a primary completion date of 2026-09-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Constitution of a biobank of tissues, whole blood and plasma samples and stools to identify markers associated with treatment response, postoperative morbidity including neuro-cognitive and mood complications and prognosis of Inflammatory Bowel disease or colorectal cancer.
Eligibility Criteria
Inclusion Criteria: * Ulcerative colitis, Crohn's disease or colorectal disease * Digestive resection with useless tissue available * Information consent signed Exclusion Criteria: \- Patients \< 18 years
Contact & Investigator
Jérémie LEFEVRE, PU-PH
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT05704413 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inflammatory Bowel Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05704413 currently recruiting?
Yes, NCT05704413 is actively recruiting participants. Contact the research team at jeremie.lefevre@aphp.fr for enrollment information.
Where is the NCT05704413 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT05704413 clinical trial?
NCT05704413 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Jérémie LEFEVRE, PU-PH at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 500 participants.